Arcadia Biosciences (RKDA) Tops Q2 EPS by 78c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of $0.61, $0.78 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance